Cargando…

Comparing Predicted Toxicities between Hypofractionated Proton and Photon Radiotherapy of Liver Cancer Patients with Different Adaptive Schemes

SIMPLE SUMMARY: The availability of high-quality image guidance and fully integrated online adaptation now allows for an efficient online adaptation for photon treatments. Since proton treatments can deliver a lower dose to healthy tissue, a combination of protons with online adaptation might furthe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nenoff, Lena, Sudhyadhom, Atchar, Lau, Jackson, Sharp, Gregory C., Paganetti, Harald, Pursley, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526201/ https://www.ncbi.nlm.nih.gov/pubmed/37760560 http://dx.doi.org/10.3390/cancers15184592

Ejemplares similares

Integrating Structure Propagation Uncertainties in the Optimization of Online Adaptive Proton Therapy Plans
por: Nenoff, Lena, et al.
Publicado: (2022)

Low-Dose Computed Tomography Scanning Protocols for Online Adaptive Proton Therapy of Head-and-Neck Cancers
por: Nesteruk, Konrad P., et al.
Publicado: (2022)

Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer
por: Hsu, Shu-Hui, et al.
Publicado: (2022)

On the molecular relationship between Hounsfield Unit (HU), mass density, and electron density in computed tomography (CT)
por: Sudhyadhom, Atchar
Publicado: (2020)

Evaluating the effect of setup uncertainty reduction and adaptation to geometric changes on normal tissue complication probability using online adaptive head and neck intensity modulated proton therapy
por: Lalonde, Arthur, et al.
Publicado: (2023)

Proton therapy physics
por: Paganetti, Harald
Publicado: (2019)

Proton therapy physics
por: Paganetti, Harald
Publicado: (2012)

The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions
por: Laine, Aaron Michael, et al.
Publicado: (2016)

Comparing Ultra-hypofractionated Proton versus Photon Therapy in Extremity Soft Tissue Sarcoma
por: Thomas, Rehema, et al.
Publicado: (2023)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

The Role of Hypofractionation in Proton Therapy
por: Santos, Alexandre, et al.
Publicado: (2022)

Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome
por: Barra, Salvina, et al.
Publicado: (2018)

A review on lymphocyte radiosensitivity and its impact on radiotherapy
por: Paganetti, Harald
Publicado: (2023)

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
por: Johansson, Silvia, et al.
Publicado: (2012)

A Three-dimensional Deformable Brain Atlas for DBS Targeting. I. Methodology for Atlas Creation and Artifact Reduction
por: Sudhyadhom, Atchar, et al.
Publicado: (2012)

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity
por: Deantonio, Letizia, et al.
Publicado: (2010)

High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities
por: HUANG, BING-SHEN, et al.
Publicado: (2013)

Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors
por: Ciammella, Patrizia, et al.
Publicado: (2014)

Hypofractionation Radiotherapy vs. Conventional Fractionation for Breast Cancer: A Comparative Review of Toxicity
por: Youssef, Ashraf, et al.
Publicado: (2018)

Comparison of peripheral leukocyte parameters in patients receiving conventionally and hypofractionated radiotherapy schemes for the treatment of newly diagnosed glioblastoma
por: Greenlund, Lindsey, et al.
Publicado: (2023)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
por: Laursen, Michael, et al.
Publicado: (2018)

Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
por: Baumann, Brian C., et al.
Publicado: (2020)

5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis
por: Kubeš, Jiri, et al.
Publicado: (2023)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Cost Minimization Analysis of Hypofractionated Radiotherapy
por: Yaremko, Hannah L., et al.
Publicado: (2021)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Pedunculopontine Nucleus Stimulation: Where are We Now and What Needs to be Done to Move the Field Forward?
por: Morita, Hokuto, et al.
Publicado: (2014)

Principles and practice of proton beam therapy
por: Paganetti, Harald, et al.
Publicado: (2015)

Impact of Choroidal Melanoma Characteristics on Progression-Free Survival in Patients Undergoing Hypofractionated Stereotactic Photon Radiotherapy
por: Told, Reinhard, et al.
Publicado: (2023)

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice
por: Piroth, Marc D., et al.
Publicado: (2021)

Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy
por: Zhang, Rui, et al.
Publicado: (2013)

Image Guided Hypofractionated Radiotherapy by Helical Tomotherapy for Prostate Carcinoma: Toxicity and Impact on Nadir PSA
por: Barra, Salvina, et al.
Publicado: (2014)

SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer: Toxicity and quality of life assessment
por: Rucinska, Monika, et al.
Publicado: (2016)

Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity
por: Chitapanarux, Imjai, et al.
Publicado: (2019)

Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis
por: Kim, Dong-Yun, et al.
Publicado: (2020)

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
por: Tamihardja, Jörg, et al.
Publicado: (2020)

Hypofractionated radiotherapy in postmastectomy locally advanced breast cancer: an interim report on acute toxicities and dosimetry
por: Jamora, Kurl, et al.
Publicado: (2022)

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
por: Pelak, Maciej J., et al.
Publicado: (2022)

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group
por: Parzen, Jacob S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_buaq13td93mr6kh2lrm9uvlh8c